Purchase Order 75N91018P00775
Award Date 9/17/18
Potential Completion Date 9/16/19
Potential Value $38K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Boston, MA 02109, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The National Cancer Institute awarded a purchase order to Mediso USA, LLC for preventative maintenance and emergency service for a SPECT/CT imaging scanner (NanoSPECT/CT, serial number NS-809037-4RCT) with a ceiling value of $44,500 and an award date of September 8, 2017. Work is performed at Bethesda, Maryland. The order is firm fixed price with an ultimate completion date of September 7, 2018. No set-aside applied.</p>
- <p>The National Cancer Institute awarded a purchase order to MR Solutions Americas, LLC for $1,145,600.00 on September 12, 2018, under a Total Small Business set-aside for a brand name or equal MR Solutions microPET/1203CT scanner system. Performance is at Bethesda, Maryland. The order carries a firm fixed price and completion date of February 28, 2019. The solicitation was posted August 9, 2018, with a due date of August 17, 2018.</p>
- <p>The National Cancer Institute awarded a purchase order to MR Solutions Inc. valued at $24,999.00 on August 2, 2018, with a completion date of September 12, 2019. No set-aside was used. Performance takes place in Acton, Massachusetts. MR Solutions Inc. manufactures advanced medical imaging equipment, including magnetic resonance imaging and positron emission tomography systems for research and medical applications.</p>
- <p>The National Cancer Institute issued a purchase order to MR Solutions Americas, LLC valued at $12,150 on September 11, 2018. Place of performance is Bethesda, Maryland. The order is a firm fixed-price commercial item acquisition with no set-aside applied. Ultimate completion is scheduled for October 11, 2018.</p>
- This firm-fixed-price purchase order was awarded by the Department of Health and Human Services' National Institutes of Health National Cancer Institute to Mediso USA, LLC, a for-profit limited liability company, on September 8, 2018. The $133,500.00 contract is for the provision of a MEDISO NANOSPECT/CT Service Agreement, with a completion date of September 7, 2021. Mediso USA, LLC is a supplier of various medical diagnostic and research imaging devices, including positron emission tomography...
- <p>The National Cancer Institute awarded a purchase order to Analogic Corporation for medical supplies on September 10, 2019, with a ceiling value of $16,709.00. Place of performance is Peabody, Massachusetts. The order carries fixed-price pricing with economic price adjustment and an ultimate completion date of September 29, 2020. No set-aside was used.</p>
- The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $13,140.54 firm fixed price purchase order to Evident Scientific, Inc. of Waltham, Massachusetts. Under the contract, Evident Scientific will provide a NANOSCAN OP400 piezo z motor drive for upright microscopes with a 400-micron travel range and load capacity up to 500 grams. Place of performance is the prime contractor's location in Waltham. The contract period of performance spans...
- <p>The National Institutes of Health's Office of Logistics and Acquisition Operations awarded a purchase order to Mediso USA, LLC for $769,640 on June 5, 2020, to supply and install a NanoScan PET122S/CT1512 small animal imaging system with accessories, discounts, and training. Performance takes place in North Bethesda, Maryland, with an ultimate completion date of October 12, 2020. The contract is firm fixed price with no small business set-aside.</p>
- <p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Mediso Usa, LLC for $1,636,580 on August 29, 2016. The order procures a MultiScan LFER 150 PET/CT in-vivo preclinical imager (model MS-L150-115V) under firm fixed-price terms. Place of performance is Boston, Massachusetts. Ultimate completion date is February 29, 2020.</p>
- <p>The National Cancer Institute awarded a purchase order to Mim Software Inc. valued at $7,350.00 on January 1, 2014, to continue scans using the Gemini PET/CT scanner and view patient images. Place of performance is Bethesda, Maryland. The order carries firm fixed pricing with an ultimate completion date of December 31, 2014.</p>
The National Cancer Institute awarded a $38,300 purchase order to Mediso USA LLC on September 17, 2018, for high-energy collimators for NanoSpect/CT imaging equipment. Work is performed in Boston, Massachusetts, under firm fixed-price terms, with an ultimate completion date of September 16, 2019. The order originated from a pre-solicitation opportunity posted September 12, 2018, with award decision made within five days of the stated due date.
Generated 8/1/26, 9:54 AM
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Mediso High Energy Collimators for NanoSPECT/CT | N02CO84107-33 | Department of Health and Human Services National Institutes of Health | Pre-Solicitation 1/1 | 9/12/18, 3:17 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $38.3k | 9/16/18 |